Review Study Says That Fluconazole Is The Only Oral Therapy For Systemic Efficacy In Cutaneous Candidiasis Supported By Evidence

Dermatology Advisor (11/20, Peckel) reports researchers conducted a review study and concluded that “the only commercially available oral therapy with evidence-based support for systemic efficacy in cutaneous candidiasis is fluconazole.” In the study publ...